These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4122138)

  • 21. Central-nervous-system complications of leukemia: a review.
    Nieri RL; Burgert EO; Groover RV
    Mayo Clin Proc; 1968 Jan; 43(1):70-9. PubMed ID: 4865325
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term follow up of central nervous system leukemia in children (author's transl)].
    Yokoyama T; Fujimoto T; Ito M; Furusho K; Kin H; Hasegawa A
    Rinsho Ketsueki; 1979 Mar; 20(3):246-52. PubMed ID: 439414
    [No Abstract]   [Full Text] [Related]  

  • 23. Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Lancet; 1973 Mar; 1(7805):727. PubMed ID: 4120530
    [No Abstract]   [Full Text] [Related]  

  • 24. Central nervous system complications in acute leukemia of childhood.
    Berkel I; Kasar C; Erozan YS
    Turk J Pediatr; 1967 Oct; 9(4):141-51. PubMed ID: 5239902
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The frequency of central nervous system manifestations in adult acute leukemia].
    Neumann E; Mittermayer K; Budka H; Honetz H; Schwarzmeier J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():654-6. PubMed ID: 1072334
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
    Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
    Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors in pathogenesis of central-nervous-system leukaemia.
    West RJ; Graham-Pole J; Hardisty RM; Pike MC
    Br Med J; 1972 Aug; 3(5822):311-4. PubMed ID: 4505467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Involvement of CNS in leukaemia and lymphomas--CSF meningeosis and immunocytochemical phenotyping].
    Lehmitz R; Pahnke J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S37-8. PubMed ID: 19685390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic strategies involving antimicrobial treatment of the central nervous system in large animals.
    Brewer BD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1217-21. PubMed ID: 6392260
    [No Abstract]   [Full Text] [Related]  

  • 31. [The nervous system complications caused by leukemia (author's transl)].
    Yu QH
    Zhonghua Nei Ke Za Zhi; 1979; 18(2):101-4. PubMed ID: 555896
    [No Abstract]   [Full Text] [Related]  

  • 32. Central nervous system (CNS) disease in Abelson virus-induced leukemia.
    Abelson HT
    Blood; 2003 Nov; 102(10):3848. PubMed ID: 14597608
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complications in the central nervous system in acute leukemia in children. Clinical contribution].
    Masera G; Carnelli V
    Minerva Pediatr; 1969 Feb; 21(8):308. PubMed ID: 5795991
    [No Abstract]   [Full Text] [Related]  

  • 34. [Induction and interval treatment of leukemias in children and juveniles].
    Oehme J; Meyer-Beeck D
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1993-6. PubMed ID: 5352272
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis and therapy of central nervous system complications of acute leukemia in childhood].
    Masera G; Carnelli V
    Haematol Lat; 1969; 12(3):831-5. PubMed ID: 5273189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neurological problems in leukemia].
    Brinch L; Evensen SA; Stavem P; Svare A
    Tidsskr Nor Laegeforen; 1988 Aug; 108(22):1587-9. PubMed ID: 3413741
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical variants of neuroleukemia].
    Lorie IuI; Finogenova IA
    Klin Med (Mosk); 1976 Jun; 54(6):31-6. PubMed ID: 1067460
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurological complications of childhood leukaemia.
    Campbell RH; Marshall WC; Chessells JM
    Arch Dis Child; 1977 Nov; 52(11):850-8. PubMed ID: 596922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current pharmacological treatment approaches to central nervous system leukaemia.
    Blaney SM; Balis FM; Poplack DG
    Drugs; 1991 May; 41(5):702-16. PubMed ID: 1712705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
    Sitarz AL; Albo V; Movassaghi N; Karon M; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(5):989-94. PubMed ID: 1106848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.